Status of hematopoietic stem cell transplantation in the WHO Eastern Mediterranean Region (EMRO)

Transfusion and Apheresis Science

Volumn 42, Issue 2, 2010, Pages 169-175

  Aljurf, Mahmoud ^a   Zaidi, Syed Z ^b   Hussain, Fazal ^a   Ghavamzadeh, Ardeshir ^c   Alimoghaddam, Kamran ^c   Jahani, Mohamad ^c   Mahmoud, Hossam Kamel ^d   Haddad, Ala'a ^d   Adil, Salman ^e   Othman, Tarek Ben ^f,g   Sarhan, Mahmoud M ^h   Dennison, David ⁱ   Ibrahim, Ahmad ^j   Benchekroun, Said ^k   Ayas, Mouhab ^a   Zahrani, Hazzaa Al ^a   Mohareb, Fahad Al ^a   Solh, Hassan El ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b Prince Sultan Hematology Oncology Center   (Saudi Arabia)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d CAIRO UNIVERSITY   (Egypt)

^e AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^f CENTRE NATIONAL DE GREFFE DE MOELLE OSSEUSE   (Tunisia)

^g Centre National de Transfusion Sanguine Tunis   (Tunisia)

^h KING HUSSEIN CANCER CENTER   (Jordan)

ⁱ SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

^j MAKASSED GENERAL HOSPITAL   (Lebanon)

^k Children's Hospital   (Morocco)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CYCLOPHOSPHAMIDE; FLUDARABINE; ISONIAZID; LAMIVUDINE;

ACUTE GRANULOCYTIC LEUKEMIA; APLASTIC ANEMIA; ARTICLE; BCG VACCINATION; BONE MARROW DEPRESSION; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINOPATHY; HEPATITIS B; HEPATITIS C; HUMAN; LYMPHOMA; PHARMACODYNAMICS; SCHISTOSOMIASIS; SICKLE CELL ANEMIA; THALASSEMIA; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT; WORLD HEALTH ORGANIZATION;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MEDITERRANEAN REGION; WORLD HEALTH ORGANIZATION;

EID: 77949656752     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2010.01.012     Document Type: Article

References (45)

1. Countries in the WHO Eastern Mediterranean Region shown on http://www.who.int/about/regions/emro/en/index.html (accessed 12.09.08).
2. Shamsi T., Hashmi K., Irfan M., et al. The stem cell transplant program in Pakistan-the first decade. Bone Marrow Transplant 42 (2008) S114-S117
3. Othman T.B., Torjemane L., Abdelkefi A., et al. Allogeneic stem cell transplantation in Tunisia. Bone Marrow Transplant 42 (2008) S139-S141
4. Mahmoud H.K., El-Haddad A.M., Fahmy O.A., et al. Hematopoietic stem cell transplantation in Egypt. Bone Marrow Transplant 42 (2008) S76-S80
5. Aljurf MD, Zaidi SZ, El Solh H, Hussain F, Ghavamzadeh A, Mahmoud HK, et al. A Gratwohl Special issues related to hematopoietic SCT in the Eastern Mediterranean Region and the first regional activity report. Bone Marrow Transplant doi:10.1038/bmt.2008.389 (01 December 2008).
6. Abdel-Rahman F., Hussein A.A., Rihani R., Hlalah O.A., et al. Bone marrow and stem cell transplantation at King Hussein Cancer Center (KHCC), Amman-Jordan. Bone Marrow Transplant 42 (2008) S89-S91
7. Dennison D., Al Kindi S., Pathare A., et al. Hematopoietic stem cell transplantation in Oman. Bone Marrow Transplant 42 (2008) S109-S113
8. Bazarbachi A., Hatoum H.A., Mugharbel A., et al. Hematopoietic stem cell transplantation in Lebanon: first comprehensive report. Bone Marrow Transplant 42 (2008) S96-S102
9. Benchekroun S., Harif M., Madani A., Quessar A., Zafad S., and Rachid R. Present and future of hematology and stem cell transplantation in Morocco. Bone Marrow Transplant 42 (2008) S106-S108
10. Sheth K.V., Elkhalifa M., Kelly T., and Sahovic E. What are the chances of finding related HLA match donors for allogeneic BMT recipients in Saudi Arabia?. Blood 88 Suppl. 1 (1996) 265b [Abstract 3787]
11. Gyger M, Sahovic E, Al Mohareb F, et al. A prospective randomized trial of marrow versus mobilized peripheral blood in HLA-matched related allogeneic transplants using a three-day short course methotrexate and cyclosporin as prophylaxis for acute graft versus host disease. Bone Marrow Transplant 2002;29(Suppl. 2):677 [Abstract 84].
12. Al Beihany A, Sahovic E, Chaudhri N, et al. Leukemia relapse after allogeneic bone marrow transplantation-how does chronic GVHD influence the pattern and onset of relapse? Bone Marrow Transplant 2005;35(Suppl. 2):S135 [Abstract 536].
13. Stem Cell Trialists' Collaborative Group. Individual patient data met-analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of day 11 methotrexate administration. Bone Marrow Transplant 2006;38:539-46.
14. Stem Cell Trialists' Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient care data meta-analysis of nine randomized trials. J Clin Oncol 2005;23:5074-87.
15. Oh H., Loberiza Jr. F.R., Zhang M.J., et al. Comparison of graft-versus-host disease and survival after HLA-identical sibling bone marrow transplantation in ethnic population. Blood 105 (2005) 1408-1416
16. Bu R., Gutierrez M.I., Al-Rasheed M., Belgaumi A., and Bhatia K. Variable drug metabolism genes in Arab population. Pharmacogenom J 4 (2004) 260-266
17. Brown K.E., Tisdale J., Barrett A.J., Dunbar C.E., and Young N.S. Hepatitis-associated aplastic anemia. N Engl J Med 336 (1997) 1059-1064
18. Hibbs J.R., Frickhofen N., Rosenfeld S.J., et al. Aplastic anemia and viral hepatitis non-A, non-B, non-C?. JAMA 267 (1992) 2051-2054
19. Druker B.J., Talpaz M., Resta D.J., et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344 (2001) 1031-1037
20. Marcucci G., Mrózek K., Ruppert A.S., et al. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study. J Clin Oncol 23 (2005) 5705-5717
21. Sahovic E, Al-Suliman A, Aslam M, et al. Successful Prevention of CMV Disease after Allogeneic BMT in 100 Consecutive CMV Seropositive Recipients. Blood 1999;94(10) [Abstract 4888].
22. Boeckh M., Bowden R.A., Gooley T., Myerson D., and Corey L. Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients. Blood 93 (1999) 1781
23. Al-Faleh F.Z. Hepatitis B infection in Saudi Arabia. Ann Saudi Med 8 (1988) 474-480
24. Ashraf Arya.S.C., Parande CM S.J., et al. Hepatitis B virus in Gizan. Saudi Arabia. J Med Virol 17 (1985) 267-274
25. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 18 Suppl. 1 (2000) S20-S22
26. Seth P., Alrajhi A.A., Kagevi I., et al. Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease. Bone Marrow Transplant 30 (2002) 189-194
27. Saeed A.A., Al-Admawi A.M., Al-Rasheed A., et al. Hepatitis C virus in Egyptian blood donors in Riyadh. Lancet 33 (1991) 359-360
28. El-Hazmi M.M. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J 25 1 (2004) 26-33
29. Mahaba H., Ael-K E.-T., and Elbaz H. The prevalence of antibodies to hepatitis C virus in Hail region, Saudi Arabia. J Egypt Public Health Assoc 74 1-2 (1999) 69-80
30. El Guneid A.M., Gunaid A.A., O'Neill A.M., Zureikat N.I., Coleman J.C., Murray-Lyon I.M., et al. C and D virus markers in Yemeni patients with chronic liver disease. J Med Virol 40 (1993) 330-333
31. Al-Ahdal M.N., Rezeig M.A., and Kessie G. Genotyping of hepatitis C virus isolates from Saudi patients by analysis of sequences from pcr-amplified core region of the virus genome. Ann Saudi Med 17 6 (1997) 601-604
32. Osoba A.O. Hepatitis C virus genotypes in Saudi Arabia. Saudi Med J 23 (2002) 7-12
33. Bdour S. Hepatitis C virus infection in Jordanian haemodialysis units, serological diagnosis and genotyping. J Med Microbiol 51 (2002) 700-704
34. Shobokshi O.A., Serebour F.E., Skakni L., Al Safy Y.H., and Ahdal M.N. Hepatitis C genotypes and subtypes in Saudi Arabia. J Med Virol 58 (1999) 44-48
35. Kabir A, Alavian S, Keyvani H. Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study. Comparative Hepatology 2006;5:4 doi:10.1186/1476-5926-5-4.
36. Aljurf M., Gyger M., Alrajhi A., Sahovic E., et al. Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients. Bone Marrow Transplant 24 (1999) 551-554
37. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients; recommendations of the CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2000;6:659-734.
38. Mahmoud H.K. Schistosomiasis as a predisposing factor to veno-occlusive disease of the liver following allogeneic bone marrow transplantation. Bone Marrow Transplant 17 3 (1996) 401-403
39. Roll Back Malaria Monitoring and Evaluation in Pakistan - WHO report .
40. Gratwohl A., Baldomero H., Horisberger B., Schmid C., Passweg J., and Urbano-Ispizua A. Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Current trends in haematopoietic stem cell transplantation in Europe. Blood 100 (2002) 2374-2386
41. Gratwohl A., Baldomero H., Frauendorfer K., and Urbano-Ispizua A. Accreditation Committee, International Society for Cellular Therapy; European Group for Blood and Marrow Transplantation; EBMT activity survey 2004 and changes in disease indication over the past 15 years. Bone Marrow Transplant 37 12 (2006) 1069-1085
42. Gratwohl A., Baldomero H., Frauendorfer K., and Niederwieser D. Why are there regional differences in stem cell transplantation activity? An EBMT analysis. Bone Marrow Transplant 42 (2008) S7-S10
43. Gratwohl A., Baldomero H., Frauendorfer K., and Gratwohl M. Apperley 1. Niederwieser D predictability of hematopoietic stem cell transplantation rates. Haematologica 92 12 (2007) 1679-1686
44. Gratwohl A., Baldomero H., Passweg J., et al. A. for the Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT) in cooperation with the Working Parties Acute (ALWP) and Chronic Leukemias (CLWP) and the Lymphoma Working Party Hematopoietic stem cell transplantation for hematological malignancies in Europe. Leukemia 17 (2003) 941-959
45. Gratwohl A., Passweg J., Baldomero H., Horisberger B., and Urbano-Ispizua A. For the Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Economics, health care systems and utilization of hematopoietic stem cell transplants in Europe. Br J Haemtol 117 (2002) 451-468